Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-21-052337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-18 | 2021-08-16 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $89.62 | -5,628 | 15.6K | -27% | -$504.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 5,628 | $89.62 | 15,608 | D | — | — | (F2) Includes 137 shares acquired under the Neurocrine Biosciences 2018 Employee Stock Purchase Plan on February 26, 2021. |